Nikhil Aggarwal
CEO & Founder – Efpia Medicine
Efpia Medicine was established with a strong mission to reshape healthcare by ensuring the availability of high-quality and affordable medicines for all. Guided by the leadership of Nikhil Aggarwal, the company has developed a broad and well-balanced product portfolio across multiple therapeutic categories. All products are manufactured at advanced facilities that strictly adhere to WHO and GMP quality standards.
With a steadfast focus on innovation, ethical business practices and continuous improvement, Efpia Medicine consistently expands its capabilities and offerings. Recognizing the challenges faced by emerging pharmaceutical enterprises, the company delivers comprehensive support to its partners, fostering long-term growth and sustainable success.
Together with its partners and stakeholders, Efpia Medicine remains committed to strengthening healthcare delivery and making a positive impact on lives nationwide.

December 2025
Awarded by Shri Nayab Singh Saini – Chief Minister of Haryana
In December 2025, Nikhil Aggarwal, CEO of Efpia Medicine, was presented with a prestigious award by Shri Nayab Singh Saini, Chief Minister of Haryana.
This honor stands as a testament to his visionary leadership, unwavering dedication and meaningful contributions toward strengthening and advancing India’s pharmaceutical industry.
October 2025
Awarded by Dr. Balbir Singh
In October 2025, Nikhil Aggarwal received a distinguished recognition from Dr. Balbir Singh, Minister of Health and Family Welfare, Punjab. This award reaffirmed his continued impact, leadership excellence and role in shaping the evolving pharmaceutical ecosystem in India.


August 2025
Awarded by Shri Gulab Chand Kataria
In August 2025, Nikhil Aggarwal was honored by Shri Gulab Chand Kataria, Governor of Punjab, in recognition of his outstanding leadership and valuable contributions to the healthcare and pharmaceutical sector. The award highlighted his strategic acumen and sustained commitment to excellence.
June 2023
Awarded by Smt. Kirron Kher
On June 1, 2023, Nikhil Aggarwal was recognized as a “Youth Role Model” by Smt. Kirron Kher. This honor reflected his visionary outlook, strategic foresight and strong emphasis on building transparent, long-term relationships across the healthcare ecosystem.
May 2023
Awarded by Shri Balbir Sidhu
On May 23, 2023, Nikhil Aggarwal received the title of “Emerging Entrepreneur of the Year – PCD Pharma” from Shri Balbir Sidhu, Minister of Health and Family Welfare, Punjab. The award acknowledged his dedication to innovation, high-quality standards and adaptability, especially during challenging periods such as the COVID-19 pandemic.
September 2021
Awarded by CM Shri Manohar Lal Khattar
On September 29, 2021, Nikhil Aggarwal was honored by Haryana Chief Minister Shri Manohar Lal Khattar for his entrepreneurial excellence and impactful contributions to the pharmaceutical industry. This recognition highlighted his forward-looking leadership, ethical business practices, and commitment to quality-driven growth.
March 2020
Awarded by Shri Navjot Singh Sidhu
On March 20, 2020, at a prominent ceremony held in Chandigarh, Nikhil Aggarwal was felicitated by Shri Navjot Singh Sidhu, Minister of Local Government, Tourism, and Cultural Affairs, Punjab. The award recognized his significant contributions over a decade, particularly in pharmaceutical research, manufacturing excellence, and distribution advancements. During his address, he emphasized the importance of teamwork, mentorship and continuous innovation.
May 2018
Awarded by Shri Brahm Mohindra
In May 2018, Nikhil Aggarwal was honored with the prestigious “Best CEO in the PCD Pharma Space” award by Shri Brahm Mohindra, Minister of Parliamentary Affairs (Health & Rural Development), Government of Punjab. This recognition acknowledged his exceptional leadership, strategic vision, and contribution to strengthening the PCD Pharma sector. Despite accolades from reputed organizations, he continues to remain focused on innovation, organizational development, and patient-centric progress.
